Elin Electronics (NSE:ELIN, BOM:543725) said a fire incident occurred at its manufacturing facility in Ghaziabad, Uttar Pradesh on May 25, according to an Indian bourse filing on Tuesday.
The company said the fire was timely controlled and no casualties or injuries were reported. A portion of the affected area will remain temporarily shut, while operations at the rest of the plant continue, it added.
Shares of the company fell nearly 2% in recent trade.
The Kansai Electric Power (TYO:9503) has agreed to resolved to transfer its behavioural change application MOACT business to a newly established wholly owned subsidiary, MOACT Inc, via a simplified incorporation-type company split.The move was approved on May 26 and scheduled for completion on July 1, according to a Tokyo bourse filing.Under the split, the new company will issue 100 shares of common stock, all to be allotted to Kansai Electric, and will succeed assets worth 279 million yen and liabilities of 54 million yen related to the MOACT business as of April 30.The MOACT business generated net sales of 15 million yen for the fiscal year ended March.
Cachet Pharmaceutical (SHE:002462) said China's State Administration for Market Regulation has approved Beijing Tongrentang's (SHA:600085) acquisition of a 28.48% stake in the company, clearing the anti-monopoly review.Upon completion, Tongrentang Group will become Cachet Pharmaceutical's controlling shareholder, according to a Tuesday filing with the Shenzhen bourse.The deal involves the transfer of 83.1 million shares from China Everbright Medical and Everbright Industrial.
Shanghai Henlius Biotech (HKG:2696) dosed the first patient in a phase 2/3 trial studying pimurutamab HLX07 in combination with Hansizhuang and chemotherapy in the Chinese Mainland, according to a Tuesday filing with the Hong Kong bourse.The drug in this combination is being compared to a placebo in combination with Hansizhuang or pembrolizumab and chemotherapy for the first-line treatment of advanced squamous non-small cell lung cancer.